| Dr Charles Paul Shenker, MD | |
|
21150 Biscayne Boulevard, Ste 208, Aventura, FL 33180 | |
| (305) 705-0501 | |
| (305) 705-0501 |
| Full Name | Dr Charles Paul Shenker |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Pulmonary Disease |
| Location | 21150 Biscayne Boulevard, Aventura, Florida |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1861437188 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | ME30420 (Florida) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Charles Paul Shenker, MD 21150 Biscayne Boulevard, Ste 208, Aventura, FL 33180 Ph: (305) 705-0501 | Dr Charles Paul Shenker, MD 21150 Biscayne Boulevard, Ste 208, Aventura, FL 33180 Ph: (305) 705-0501 |
News Archive
McCord Research, Inc., founded by Darlene McCord, Ph.D., FAPWCA, has produced a valuable guide to help people with diabetes take care of their feet for a lifetime. Dr. McCord has over 30 years of experience in the skin and wound care industry. Ten years ago she also created the most successful skin and wound care product line in North America.
Biologists tend to look at cells in bulk, observing them as a group and taking the average behavior as the norm - the assumption is that genetically identical cells all behave the same way.
Curis, Inc., announced today that its licensee Debiopharm S.A. has received approval from France's regulatory authority Agence Française de Securité Sanitaire des Produits de Santé (AFSSAPS) of a Clinical Trial Application (CTA) for small molecule heat shock protein 90 (Hsp90) inhibitor Debio 0932, formerly called CUDC-305. Under the terms of Curis' and Debiopharm's August 2009 license agreement, Curis will receive an $8 million milestone payment from Debiopharm for the achievement of this development objective.
The Indiana University Philanthropic Venture Fund, which provides capital to faculty, students, alumni and staff at all IU campuses to help them further develop their research and innovations into startup companies, has committed to invest $500,000 in Indianapolis-based NERx Biosciences Inc. as part of a $2.2 million bridge round.
› Verified 7 days ago
Mr. Solomon Leo Lerer, M.D., F.A.C.G., Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 21110 Biscayne Blvd, # 303, Aventura, FL 33180 Phone: 305-931-6220 Fax: 305-466-4755 | |
Dr. David Yitzchok Manela, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 2820 Ne 214th St Ste 902, Aventura, FL 33180 Phone: 213-509-5115 | |
Dr. Steven Kobrin, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 2801 Ne 213th St Ste 101, Aventura, FL 33180 Phone: 305-466-7333 Fax: 786-651-2177 | |
Luis Jorge Echarte, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 21110 Biscayne Blvd, Suite 303, Aventura, FL 33180 Phone: 305-466-0030 Fax: 305-466-4755 | |
Nelson Perez Mateu, M.D Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 20601 E Dixie Hwy Ste 340, Aventura, FL 33180 Phone: 786-923-4000 | |
Leonard J Pianko, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 21097 Ne 27th Ct Ste 110, Aventura, FL 33180 Phone: 305-384-4720 Fax: 305-933-1749 | |
Jay E Reinberg, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2845 Aventura Blvd, Suite 247, Aventura, FL 33180 Phone: 305-932-9880 Fax: 305-932-1035 |